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Importance 
West Nile virus (WNV) is a mosquito-borne virus that circulates among birds, 
but can also affect other species, particularly humans and horses. Many WNV strains 
are thought to be maintained in Africa; however, migrating birds carry these viruses 
to other continents each year, and some strains have become established outside 
Africa. At one time, the distribution of WNV was limited to the Eastern Hemisphere, 
and it was infrequently associated with serious illness. Clinical cases usually occurred 
sporadically in humans and horses, or as relatively small epidemics in rural areas. 
Most human infections were asymptomatic, and if symptoms occurred, they were 
typically mild and flu-like. Severe illnesses, characterized by neurological signs, 
seemed to be uncommon in most outbreaks. Birds appeared to be unaffected 
throughout the Eastern Hemisphere, possibly because they had become resistant to the 
virus through repeated exposure.  
Since the 1990s, this picture has changed, and WNV has emerged as a significant 
human and veterinary pathogen in the Americas, Europe, the Middle East and other 
areas. Severe outbreaks, with an elevated case fatality rate, were initially reported in 
Algeria, Romania, Morocco, Tunisia, Italy, Russia and Israel between 1994 and 1999. 
While approximately 80% of the people infected with these strains were still 
asymptomatic, 20% had flu-like signs, and a small but significant percentage (<1%) 
developed neurological disease. One of these virulent viruses entered the U.S. in 
1999. Despite control efforts, it became established in much of North America, and 
spread to Central and South America and the Caribbean. Outbreaks were reported 
across North America in humans, horses and captive alligators; sporadic cases 
occurred in less susceptible mammals; and asymptomatic infections were recognized 
in a number of mammalian and several reptilian species. Although the introduction of 
an equine vaccine has helped control the disease in horses, there is currently no 
vaccine for humans, and recent experiences suggest that human outbreaks may 
continue to occur in North America at unpredictable intervals. Many North American 
species of birds were also affected, particularly when the virus first entered the 
continent. While some bird populations seem to have rebounded, the effect of WNV 
on threatened or endangered avian species continues to be a concern. California 
condors and greater sage grouse are among the species susceptible to this virus, and 
any WNV introduction into Hawaii could have severe consequences for some native 
birds. Surprisingly, the effects of virus introduction seem to have been milder in 
South America, although the reason for this is still uncertain.  
The epidemiology of WNV infections may also be changing in Eurasia. A 
number of outbreaks have been reported recently in Europe, Russia and parts of the 
Middle East. One virus affected significant numbers of wild and captive raptors in 
Hungary and Austria. This has led to a re-examination of the potential for West Nile 
viruses to cause illness or deaths in other European birds. Some viruses, which were 
not thought to persist from year to year in Europe, seem to have become endemic and 
are spreading.  
Etiology 
West Nile virus is an arbovirus in the Flavivirus genus of the family Flaviviridae. 
It belongs to the Japanese encephalitis virus complex or serogroup. The two most 
common genetic lineages of WNV are lineage 1, which contains 3 clades (1a, 1b and 
1c), and lineage 2. Both lineages contain virulent viruses, as well as strains that 
usually cause asymptomatic infections or mild disease. Many of the virulent viruses 
from recent outbreaks belonged to clade 1a, which is widespread. The strain that 
entered the United States in 1999, called NY99, appears to be related to a lineage 1a 
virus found in Israel from 1997 to 2000, and is among the most pathogenic strains. 
NY99 has continued to evolve in the Americas, where it has been replaced by its 
variants, especially WN02. Clade 1b consists of Kunjin virus, a subtype of WNV 
found in Australia, and clade 1c consists of some West Nile viruses found in India.  
Several additional WNV lineages also exist or have been proposed. Under some 
taxonomic schemes, it might be possible to classify this virus into as many as eight  
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lineages by including Koutango virus, a related virus that 
circulates in Africa, and elevating clades 1b and 1c to 
lineages. 
Species Affected 
Birds 
Wild birds are the main reservoir hosts for West Nile 
virus. Passeriformes (perching birds) are important in virus 
amplification. Some members of other orders including (but 
not limited to) Charadriiformes (shorebirds), Falconiformes 
(hawks, eagles, vultures and related species) and 
Strigiformes (owls) may also transmit the virus to 
mosquitoes.  
Birds in the Western hemisphere 
Overall, WNV-infections have been documented in 
more than 320 species of North American birds since 1999. 
Some species usually carry the virus asymptomatically, 
while others are more likely to become ill. Clinical cases 
have been reported in domesticated birds, wild birds, and 
captive wild species in zoos and collections. 
Among domesticated birds, outbreaks have occurred in 
geese, and symptomatic infections have been reported in a 
number of psittacine species (although psittacine birds were 
relatively resistant to disease in one experimental study). 
Chickens and turkeys (order Galliformes) seroconvert but 
remain asymptomatic; however, outbreaks have occurred in 
farmed chukar partridges (Alectoris chukar) and Impeyan 
pheasants (Lophophorus impeyanus). Some wild 
gallinaceous birds have also been affected: greater sage 
grouse (Centrocercus urophasianus) are highly susceptible, 
and one case was reported in a wild turkey (Meleagris 
gallopavo ssp).  
The effects of WNV on wild birds vary with the 
species. When this virus was first introduced to North 
America, corvids (e.g., crows, ravens, magpies and jays) 
were severely affected. Other affected wild birds have 
included American robins (Turdus migratorius), eastern 
bluebirds (Sialia sialis), chickadees (Poecile sp.), tufted 
titmice (Baeolophus bicolor), house finches (Carpodacus 
mexicanus), house sparrows (Passer domesticus), house 
wrens (Troglodytes aedon) and black-crowned night herons 
(Nycticorax nycticorax). Northern cardinals (Cardinalis 
cardinalis) also seem to be susceptible, although the 
population as a whole appears to be resilient and did not 
decline. High mortality rates have been reported in infected 
Falconiformes, and owls have also been killed. Emus, 
penguins, pigeons, flamingos, American white pelicans 
(Pelecanus erythrorhyncos) cormorants, gulls, sandhill 
cranes (Grus canadensis) and other species can also be 
affected. Although ducks are not thought to be highly 
susceptible, there have been reports of illness in several 
species, or their young. 
Similarly to the pattern of disease in humans, birds in 
South and Central America, Mexico and the Caribbean 
seem to be less severely affected than birds in North 
America. However, this might vary with the viral strain and 
species of bird. One WNV isolate from Mexico was less 
virulent for crows, but not house sparrows, compared to a 
North American virus. 
Birds in the Eastern Hemisphere 
WNV outbreaks have been reported among 
domesticated geese in the Eastern Hemisphere, but 
generally there have been only sporadic reports of deaths in 
individual wild birds. It is uncertain whether this is related to 
the virulence of the viruses circulating in this region, host 
susceptibility, reduced transmission/ amplification or lack of 
surveillance. One recently introduced lineage 2 virus in 
Central Europe has affected significant numbers of wild and 
captive raptors. Species known to be susceptible to this 
isolate include sparrow hawks (Accipiter nisus), goshawks 
(Accipiter gentilis) and gyrfalcons (Falco rusticolus). The 
same virus was isolated from a dead collared dove 
(Streptopelia decaocto) in Italy, during an outbreak of 
mortality in collared doves and other species including 
blackbirds. Lineage 1a or 2 viruses have also been found 
occasionally in other sick or dead birds including European 
robins (Erithacus rubecula), a raven (Corvus corax), 
common magpies (Pica pica), a Eurasian jay (Garrulus 
glandarius), house sparrows (Passer domesticus), a black 
redstart (Phoenicurus ochruros), a sedge warbler 
(Acrocephalus schoenobaenus) and a Savi’s warbler 
(Locustella luscinioides). 
European birds that became ill when infected 
experimentally with WNV outbreak strains from the 
Eastern Hemisphere included falcons that received 
European lineage 1 or lineage 2 viruses; red legged 
partridges (Alectoris rufa) infected with a European lineage 
1 virus; house sparrows infected with European lineage 1 
viruses; and wild carrion crows (Corvus corone) inoculated 
with lineage 1 isolates from Europe or Israel. Most 
European species have not yet been examined for 
susceptibility.  
Mammals and marsupials 
Among mammals, disease occurs mainly in equids 
(horses, donkeys and mules). Although serious illnesses in 
horses have mainly been attributed to lineage 1 viruses, 
lineage 2 isolates in Africa and Hungary also caused 
severe clinical signs or death.  
A few clinical cases have been reported in other 
domesticated mammals including alpacas, sheep and 
reindeer (Rangifer tarandus). Dogs and cats appear to be 
readily infected, but rarely become ill. Wild or captive wild 
species that have been affected include squirrels, harbor 
seals (Phoca vitulina), a killer whale (Orcinus orca), Indian 
rhinoceroses (Rhinoceros unicornis), wolf pups, a polar 
bear (Ursus maritimus), a Barbary macaque (Macaca 
sylvanus), mountain goats (Oreamnos americanus) and a 
white-tailed deer (Odocoileus virginianus). Experimental 
infections have been established in a variety of mammals: 
mice, hamsters, chipmunks, cats and rhesus monkeys 
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developed mild to severe clinical signs, but rabbits, pigs, 
guinea pigs, dogs, raccoons and hedgehogs (Erinaceus 
europaeus) remained asymptomatic.  
Antibodies to WNV have been found in many 
mammalian and some marsupial species including cattle, 
sheep, goats, pigs, camels, wild boar, deer, lemurs, bats, 
skunks, bears, coyotes, foxes, various big cats (e.g., tiger, 
lion, cougar), stone marten (Martes foina), a civet, raccoons 
(Procyon lotor), opossums, rabbits, non-human primates, 
killer whales, dolphins, seals, small rodents and 
insectivores. Due to the limitations of serological testing for 
WNV, some of these antibodies may represent infections 
with flaviviruses other than WNV.  
Some species of mammals including squirrels (Sciurus 
sp.), eastern chipmunks (Tamias striatus) and eastern 
cottontail rabbits (Sylvilagus floridanus) may be capable of 
transmitting WNV to mosquitoes, although their 
importance as reservoir hosts is still uncertain. Individual 
animals of certain other species, such as raccoons (Procyon 
lotor), may develop moderate levels of viremia, even if the 
species overall is not considered to be of epidemiological 
significance in infecting mosquitoes.  
Reptiles and amphibians 
Among reptiles, clinical signs were mainly reported 
during outbreaks in alligators, although there is also a report 
of neurological signs associated with WNV infection in a 
crocodile monitor (Varanus salvadori) lizard. Some 
infections in garter snakes (Thamnophis sirtalis) 
experimentally inoculated with WNV were also fatal. Green 
iguanas (Iguana iguana) can be infected, and antibodies 
have been found in turtles, wild and farmed crocodiles, and 
alligators.  
Amphibians including lake frogs (Rana ridibunda) and 
North American bullfrogs (Rana catesbeiana) can also be 
infected with WNV.  
Some alligators (e.g., American alligators, Alligator 
mississippiensis) and frogs (e.g., Rana ridibunda in Russia) 
may develop viremia sufficient to infect mosquitoes. As 
with mammals, their importance as reservoir hosts is still 
uncertain. 
Zoonotic potential 
Humans are susceptible to West Nile virus. 
Geographic Distribution 
West Nile viruses have been found throughout much 
of the world including Africa, Europe, Asia, the Middle 
East, Australia, the Americas and the Caribbean. In some 
regions, the viruses do not seem to be endemic, but are re-
introduced regularly by migratory wild birds. These viruses 
may either cause outbreaks, or circulate asymptomatically 
among birds during warm weather, and disappear with the 
onset of cold temperatures. Relatively little is known about 
the occurrence of WNV in Asia, where the presence of the 
closely-related Japanese encephalitis virus (JEV) 
complicates diagnosis. However, WNV is endemic in India, 
and it was recently reported from an outbreak in China that 
was originally thought to be caused by JEV. 
Lineage 1 WNV 
In the Eastern Hemisphere, lineage 1a viruses have 
been found in Africa, the Middle East, Europe and parts of 
Asia. Whether these viruses circulate in any avian 
populations in Europe, or are only introduced periodically 
by wild birds without overwintering, is still under 
investigation. Currently, it appears that many lineage 1 
viruses do not overwinter, while others may persist from 
year to year in the Mediterranean region, but not in some 
other countries that have been examined (e.g., the U.K. and 
Germany). There is also evidence for the continuing 
endemic circulation of a lineage 1 virus in Romania 
between 1997 and 2009, after an epidemic in 1996. In the 
Western Hemisphere, lineage 1a viruses have been endemic 
in North America since 1999. Since spreading to South and 
Central America, they have been documented in several 
countries including Colombia, Argentina, Venezuela and 
Brazil. WNV has also spread to the Caribbean, but it is not 
yet present in Hawaii in 2013.  
Lineage 1b (Kunjin virus) occurs in Australia, and 
lineage 1c viruses are found in India. 
Lineage 2 WNV 
Lineage 2 viruses have mainly been isolated south of 
the Sahara desert in Africa, where they co-circulate in some 
regions with lineage 1 viruses. They also occur in 
Madagascar. Virulent lineage 2 strains have been endemic 
in Central Europe (Hungary and Austria) since 2004, and 
seem to be spreading. Identical or closely related viruses 
were recently isolated from mosquitoes, a dead indigenous 
bird and two human patients in Italy, and from mosquitoes 
in Greece during a human WNV outbreak. Different lineage 
2 viruses caused outbreaks in Russia in 2007, and viruses 
related to this strain were found in Romanian outbreaks in 
2010. One genetic analysis suggested that the viruses 
originally identified in Hungary and Russia might have 
been introduced in 1999 and 2000, respectively. 
Transmission 
West Nile virus is primarily transmitted by mosquitoes. 
Members of the genus Culex are the main vectors worldwide, 
although other mosquito genera can also be infected. In 
North America alone, there is evidence of infection in more 
than 60 mosquito species. Transovarial transmission has been 
demonstrated in some species of mosquitoes, and is likely to 
important in overwintering. Dormant mosquitoes that survive 
the winter may also harbor WNV. Other arthropods might 
have minor roles in transmission. Infections have been 
documented in ticks in Asia, Europe and the Middle East, 
and soft (argasid) ticks have been shown to transmit WNV in 
the laboratory. Hippoboscid flies might be able to transmit 
this virus in North America, and infected lice (Philopterus 
spp.) have been collected from WNV-infected crows.  
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Birds are the primary vertebrate reservoir hosts for 
West Nile virus, but the level and duration of viremia 
varies with the species. In endemic regions, the virus is 
maintained in an enzootic cycle between culicine 
mosquitoes and birds. When environmental conditions 
favor high viral amplification, significant numbers of 
“bridge vector” mosquitoes (mosquitoes that feed on both 
birds and mammals) become infected in the late summer, 
and can transmit the virus to humans, horses and other 
incidental hosts. In some birds, viremia can persist for 
more than three months, possibly contributing to the 
overwintering of the virus. Whether birds harbor sufficient 
infectious virus to initiate a new cycle in mosquitoes, after 
the winter, is still under investigation. Migratory birds are 
thought to be important in introducing WNV into new 
areas, and can reintroduce viruses into some regions each 
year.  
Some species of birds can shed WNV in oral and 
cloacal secretions, and may transmit the virus directly. 
Crows, jays, magpies, gulls, raptors and some other birds, 
including domesticated chickens and turkeys, are known 
to excrete WNV for varying periods of time, and evidence 
for horizontal transmission was reported during an 
outbreak in domesticated geese. However, not all birds 
that shed WNV seem to transmit the virus efficiently. 
Experimentally infected red-legged partridges (Alectoris 
rufa) excreted this virus in oral and cloacal secretions, but 
there was no evidence of transmission to birds in contact. 
WNV also occurs in the skin of geese and the blood-
feather pulp of crows, possibly contributing to 
transmission by cannibalism and feather picking. Raptors 
and crows may become infected when they eat other 
animals, and insectivorous species might eat infected 
mosquitoes. WNV does not seem to persist very long in 
the environment: the infectivity of virus in avian feces 
decreases dramatically after 24 hours.  
Mosquito bites are the usual source of WNV for 
mammals, reptiles and amphibians. Most animals, 
including horses, appear to be dead-end hosts that do not 
transmit WNV to mosquitoes, but a few species have 
higher levels of viremia, and might be able to act as 
amplifying or maintenance hosts. In some animals, there 
is also evidence for transmission by other routes. 
Carnivorous mammals and reptiles (e.g., cats and 
alligators) can be infected by eating contaminated tissues. 
WNV-contaminated horsemeat was implicated in one 
outbreak in alligators. Direct transmission during close 
contact has also been reported in alligators, possibly via 
fecal shedding of virus. Chipmunks, squirrels and 
raccoons can also shed WNV in feces, oral secretions 
and/or urine. WNV has been found in the urine of 
experimentally infected hamsters, and in very small 
amounts in the oral and/or cloacal fluids of experimentally 
infected North American bullfrogs (Rana catesbeiana) 
and green iguanas (Iguana iguana). Transplacental 
transmission was reported in experimentally infected 
sheep and mice, as well as in a horse that was fatally 
infected with a lineage 1 virus in Africa, and aborted in 
the final stage of the disease. The epidemiological 
significance (if any) of mammalian, reptilian and 
amphibian hosts in the maintenance or amplification of 
WNV remains to be established. 
Humans are usually infected by mosquito bites, but a 
few cases have been linked to accidental inoculation 
through breaks in the skin. These cases frequently 
occurred in people who handled infected tissues (often 
brains) from various animals. One recent infection 
occurred in a person who had removed the brain of an 
infected horse, using only latex gloves for protection. 
Whether the gloves had an unnoticed small puncture, or 
there was another source of the virus, is uncertain. An 
outbreak among workers on a turkey farm may have 
resulted from fecal-oral transmission, exposure of broken 
skin or mucous membranes to virus, or exposure to 
aerosolized virus. Humans do not develop viremia 
sufficient to transmit WNV to mosquitoes, and do not 
appear to shed significant levels of infectious virus in 
secretions or excretions. While WNV RNA is often found 
in patients’ urine, infectious virus was only isolated from 
one encephalitis patient who had a very high viral load, 
and other isolation attempts on urine have been 
unsuccessful. For this reason, a recent article concluded 
that human urine is probably not a risk for virus 
transmission. However, WNV can be transmitted between 
people in blood transfusions and organ transplants. Rare 
cases of transplacental transmission and probable 
transmission in breast milk have also been reported.  
In mammals, WNV is usually cleared from the body 
during the illness. A few studies have suggested that this 
virus or its RNA might persist for up to several months, or 
perhaps even years, in some mammals including humans. 
The evidence is currently conflicting, and this issue has not 
yet been resolved. 
Disinfection 
West Nile virus can be destroyed by many disinfectants 
including sodium hypochlorite solutions (500-5000 ppm 
available chlorine), 2-3% hydrogen peroxide, 2% 
glutaraldehyde, 3-8% formaldehyde, ethanol, 1% iodine 
and phenol iodophors. It is also inactivated by UV light and 
gamma irradiation, as well as exposure to temperatures of 
56-60°C (133-140 °F) for 30 minutes. 
Infections in Animals 
Incubation Period 
The incubation period in horses is 3 to 15 days. 
Infections in other mammals are uncommon, and the 
incubation period is unknown. Clinical cases are reported to 
occur in birds, on average, approximately 5 days after 
experimental inoculation. 
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Clinical Signs 
Birds 
Some species of birds carry WNV asymptomatically, 
while others develop clinical signs. Trauma (e.g., as a 
consequence of neurological signs) or concurrent bacterial, 
fungal or viral infections may also complicate the course of 
the disease. 
On poultry or game bird farms, outbreaks have been 
reported in geese, chukar partridges and Impeyan 
pheasants. Only young geese were affected during 
outbreaks in North America and Israel; older birds did not 
become ill. The clinical signs in goslings included weight 
loss, decreased activity, depression, and neurological signs 
such as torticollis, opisthotonos and rhythmic side-to-side 
head movements. Myocarditis was seen in some birds at 
necropsy. Many infections were fatal. Illness has also been 
reported in chukar partridges and Impeyan pheasants. In 
one outbreak, hundreds of 6-8-week-old chukar partridges 
were either found dead without previous clinical signs, or 
displayed incoordination for less than a day before dying. 
Incoordination and diarrhea, followed by death, were 
reported in Impeyan pheasants. Naturally or experimentally 
infected chickens and turkeys are asymptomatic regardless 
of age. 
A variety of clinical signs have been reported in zoo 
birds, pet psittacines and captive raptors. The predominant 
signs and course of the disease can vary with the species. 
Nonspecific signs such as anorexia, rapid weight loss, 
weakness, lethargy and ruffled feathers are common; some 
birds display only nonspecific signs before death. 
Neurological signs also occur in some birds; ataxia, 
incoordination, paresis or paralysis, disorientation, tremors, 
nystagmus, impaired vision or blindness, circling and 
seizures have been reported. Myocarditis is sometimes seen 
at necropsy. Sudden death also occurs. In contrast, one 
great horned owl had intermittent, mild clinical signs for 
more than five months, and a vulture with neurological 
signs exhibited progressive deterioration over the course of 
three weeks. In early reports, most clinically affected birds 
died or were euthanized due to their deteriorating condition. 
However, some birds, including those with neurological 
signs, can recover with supportive care. Full recovery can 
sometimes take longer than 6 months in raptors. Sequelae 
that have been reported in recovered birds of prey include 
relapses of neurological signs (e.g., ataxia), abnormal 
molting and persistently abnormal feathers. 
Affected wild birds are usually found dead, and the 
clinical signs in many species have not been well described. 
Neurological signs have been reported in some moribund 
birds, and myocarditis, encephalitis or other lesions are 
sometimes found at necropsy. Experimentally infected sage 
grouse developed a profuse, clear, watery oral and nasal 
discharge. Affected birds ruffled their feathers, shivered, 
isolated themselves from the group, and showed signs of 
weakness or lethargy. These signs were followed by 
drooping wings, ataxia, copious oral and nasal secretions, 
and labored breathing. The grouse became moribund within 
hours.  
Mammals 
Most horses are infected asymptomatically with WNV. 
In clinical cases, the illness is characterized by anorexia, 
depression and neurological signs, which may include ataxia, 
weakness or paralysis of one or more limbs, teeth grinding, 
aimless wandering, convulsions and/or circling. Tremors of 
the face and neck muscles are very common. Some animals 
have cranial nerve deficits, particularly weakness or paralysis 
of the face and tongue, which may lead to difficulty in 
swallowing. Attitudinal changes including somnolence, 
apprehension, hyperesthesia or periods of hyperexcitability 
are also common. Some horses with severe depression and 
facial paralysis may hang their heads; this can result in severe 
facial edema. Coma, impaired vision and head pressing can 
be seen, but tend to be less common than in cases of 
encephalitis caused by alphaviruses. Colic and urinary 
dysfunction (from mild straining to stranguria) have also 
been reported. Fever is present in some but not all cases. 
Fatal hepatitis was seen in a donkey with neurological signs 
in France. Injuries, pulmonary infections acquired during 
prolonged recumbency, and other secondary effects can 
complicate the course of the disease in equids. Some animals 
die spontaneously, but many severely affected animals are 
euthanized for humane reasons. Horses that recover usually 
begin to show improvement within seven days of the onset of 
clinical signs. Most but not all horses return to full function; 
approximately 10-20% horses are estimated to have residual 
defects such as weakness in one or more limbs, decreased 
exercise tolerance, muscle atrophy or behavioral changes. 
Studies from outbreaks in Hungary suggest that the lineage 2 
virus circulating in Central Europe causes similar clinical 
signs and mortality as lineage 1a strains in horses. 
Clinical cases have also been reported in ruminants and 
cervids, although they seem to be uncommon. In many 
cases, only a single animal was affected on a farm. 
Occasionally, a few other animals became ill around the 
same time. Most affected sheep, alpacas, reindeer and 
white-tailed deer have had neurological signs, which were 
often the first signs observed in the animal. However, a 
prodromal syndrome of fever, anorexia and depression was 
reported in one alpaca; the fever disappeared by the time 
the neurological signs appeared. Sudden death without prior 
clinical signs was seen in a reindeer. Another reindeer had 
diarrhea for 1-2 weeks before the onset of neurological 
signs. Most affected animals have died, but one alpaca 
recovered from mild head tremors and ataxia. Death often 
occurs within 1-2 days, particularly in reindeer, but some 
animals were ill for several days to a week. Experimentally 
infected sheep did not develop systemic signs, but some 
pregnant ewes aborted, had stillborn lambs, or gave birth to 
lambs that died soon after birth.  
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Neurological signs, sometimes accompanied by other 
clinical signs, have been reported from rare clinical cases in 
dogs and wolf pups. In one dog, the first signs were episodes 
of uncontrolled rolling, which quickly progressed to 
generalized tremors, ataxia and intermittent fever. Other 
neurological signs reported in dogs were decreased conscious 
proprioception, a stiff gait, neck pain, paresis, depressed 
mentation, muscle atrophy and head tilt. Fever, inappetence, 
oculonasal discharge, conjunctivitis, excessive salivation, 
polydypsia, diarrhea, abdominal pain, myocarditis, dyspnea 
and polyarthritis have also been seen. Asymptomatic 
infections appear to be common, and only mild recurrent 
myopathy was reported in experimentally infected dogs. 
Oculonasal discharge, vomiting, anorexia, and lethargy, 
progressing to ataxia, were reported in a 4-month-old wolf 
cub. This animal died 24 hours after the onset of 
neurological signs. West Nile virus was also recovered 
from the brain of a cat with CNS signs. Experimentally 
infected cats were transiently lethargic and had fluctuating 
fevers, but neurological signs were not seen. 
Cases in other animals have also been characterized 
mainly by neurological signs or sudden death, with 
systemic signs in some instances. Some infected squirrels 
circled, chewed at their feet, were lethargy or ataxic; other 
squirrels have been found dead. Incoordination, tremors and 
head tilt were reported in one of ten experimentally infected 
fox squirrels (Sciurus niger); the other nine squirrels 
remained asymptomatic. Acute paraparesis was the 
presentation in an aged polar bear at a zoo, while a fatal 
infection in a harbor seal was characterized by progressive 
neurological signs, inappetence and weakness, with 
intermitted diarrhea and vomiting, and labored breathing. 
Tremors and twitching were seen in another captive seal for 
four days, but this animal recovered. Sudden death occurred 
in a captive killer whale that had fulminant secondary 
bacteremia and septicemia, together with primary WNV 
encephalitis. West Nile virus was also suspected as the 
cause of depression, lethargy, partial anorexia and a 
drooping lip in two Indian rhinoceroses during a WNV 
outbreak at a zoo. Both animals recovered. Infections in 
some experimentally infected mice, hamsters and rhesus 
monkeys were characterized by fatal encephalitis. 
Experimentally infected pigs remained asymptomatic. 
Reptiles 
In alligators, the clinical signs included anorexia, 
lethargy, weakness and neurological signs including tremors, 
unresponsiveness, slow reflexes, head tilt, anisocoria and 
opisthotonos. Some alligators were unable to submerge and 
stranded in dry parts of the pen, dragged their hind feet, or 
swam on their sides or in circles. Animals usually died 24–48 
hours after the onset of clinical signs. A strong association 
between WNV infection and lymphohistiocytic proliferative 
cutaneous lesions has also been reported in this species.  
Neurological signs in one naturally infected crocodile 
monitor were also linked to WNV. Fatal illness was 
reported in experimentally infected garter snakes. Some 
snakes died suddenly, while others exhibited unusual 
aggression and immobility of the caudal part of the body, or 
weakness and cachexia, which may have been caused by 
inappetence.  
Post Mortem Lesions 
Birds 
A wide variety of gross and microscopic lesions, which 
are often nonspecific, have been reported in birds. Some 
birds may be thin or emaciated, but others are in good body 
condition. The most common macroscopic lesions, in 
addition to emaciation and dehydration, are multiorgan 
hemorrhages, petechiae and congestion. Splenomegaly, 
hepatomegaly, myocardial pallor and pale mottling of the 
liver, spleen or kidney have also been observed in various 
species. Several reports described cerebral atrophy and 
malacia in raptors. Gross lesions seem to be minimal or 
absent in some infected birds, including some psittacines. 
No macroscopic lesions appear to be pathognomonic for 
WNV, and reported lesions are not necessarily consistent 
between species, even when the birds belong to the same 
family. The limited number of samples from some species 
may contribute to the seeming high variability in gross 
lesions. 
Histopathologic lesions have been detected in most 
organs, but in most families of birds, lesions are usually 
concentrated in the CNS (e.g., encephalitis), heart, spleen, 
liver and kidney. Frequently reported findings include 
lymphoplasmacytic and histiocytic infiltrates, cellular 
degeneration and necrosis, and hemorrhages. The pattern 
and severity of microscopic lesions vary with the species of 
bird and the length of time it has been ill. In birds that die 
quickly, the lesions may be acute and have minimal 
inflammatory reactions. Birds that have been ill longer, 
such as raptors, can have chronic lesions, including lesions 
in the CNS. Severe CNS lesions are not always found in 
birds with neurological signs.  
Mammals 
Gross lesions are uncommon in horses. If they occur, 
they are usually limited to small multifocal areas of 
discoloration and hemorrhage in the spinal cord, brain stem 
and midbrain. The meninges may be congested in acute 
cases. Meningeal hemorrhages have also been described. 
Gross lesions in tissues other than the CNS are uncommon. 
The histopathologic lesions are characterized by 
lymphocytic or histiocytic poliomeningoencephalitis with 
perivascular cuffing of mononuclear cells, neuronal 
degeneration, neuronophagia and focal gliosis. These 
lesions are particularly apparent in the lower brain stem and 
spinal cord, and may also occur in the midbrain. They are 
less common in the cerebral and cerebellar cortices. Mild 
nonsuppurative myocarditis, scattered hemorrhages in the 
renal medulla, and lymphoid depletion of the spleen have 
been seen in some horses. 
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Few or no gross lesions have been reported in most 
other mammals including reindeer, squirrels, sheep and 
alpacas. In one sheep, multifocal hemorrhagic and malacic 
foci were found in the lumbar spinal cord. A wolf pup was 
emaciated, with mucoid nasal exudate, and unclotted blood 
was found in the small and large intestinal lumen. This 
animal also had vascular lesions in the kidneys, and to a 
lesser extent, in the cerebral cortex. The liver, which was 
mildly enlarged, was yellow and friable; hepatic lipidosis 
was partly attributed to anorexia. In a harbor seal, gross 
lesions included decreased blubber thickness and hyperemia 
of the brainstem and spinal cord blood vessels. In 
mammals, histological lesions in the CNS have generally 
resembled those seen in horses. Lymphocytic and 
necrotizing myocarditis, granulomatous inflammation of the 
kidneys, renal tubular epithelial cell necrosis, pancreatitis, 
synovitis (polyarthritis) and acute, diffuse, moderate hepatic 
necrosis were also reported in affected dogs. Mild to 
moderate lymphocytic myocarditis, myocardial necrosis 
and mild focal hepatic necrosis were seen in some squirrels. 
Reptiles 
During an outbreak in alligators, moderately sized fat 
bodies and approximately 3–5 ml of clear yellow fluid were 
found in the coelomic cavity. The liver was mottled red to 
yellow, and slightly enlarged with rounded edges. Tan to 
red mottling was also seen in the spleen and myocardium. 
Diagnostic Tests 
WNV infections can be diagnosed by isolating the 
virus, detecting viral antigens or RNA, or using serological 
methods. The usefulness of the various techniques varies 
with the level of virus replication in the host. In horses, 
viremia is short-lived and low, and clinical cases are usually 
confirmed by serology, or by detecting WNV in the brain 
and spinal cord at necropsy. Both serology and tests to 
detect the virus are useful in live birds, with the caveat that 
the amount of virus can vary between avian species. There 
is limited information about other animals; however, virus 
replication seems to be widespread in affected alligators, 
while viremia appears to be low in ruminants. 
Isolation of West Nile virus can be used for diagnosis, 
especially when disease is suspected in a species not 
previously known to be susceptible. WNV is often 
recovered in African green monkey kidney (Vero) cells or 
rabbit kidney (RK-13) cells. Mosquito cell lines and 
embryonating chicken eggs may also be used. The identity 
of the virus can be confirmed by tests such as 
immunofluorescence or RT-PCR. In birds, WNV is 
sometimes found in the blood, and it can often be isolated 
from the CNS and/or major organs (e.g., heart and liver) at 
necropsy. This virus was also recovered from plasma and 
several tissues in affected alligators. In one outbreak, viral 
titers were reported to be higher in the liver of alligators 
than the CNS. In horses, WNV is difficult to isolate from 
the blood, but it can sometimes be found in the brain and 
spinal cord at necropsy. Disadvantages to virus isolation are 
that it is time-consuming, requires level 3 biosafety (BL 3) 
containment, and is not widely available at diagnostic 
laboratories. 
RT-PCR assays are valuable as both antemortem and 
postmortem tests in birds. In some live birds, this test may 
be able to detect West Nile virus RNA in oral and cloacal 
swabs and/or serum samples. Viral RNA was also found in 
plasma samples from sick alligators. In horses, RT-PCR is 
most useful with brain and spinal cord samples taken at 
necropsy. Although viral RNA can sometimes be found in 
the blood of subclinically infected horses, it has usually 
disappeared by the time the neurological signs appear. In 
addition, RT-PCR has been used to diagnose WNV 
infections in other animal species. Some commercial assays 
may not detect lineage 2 viruses.  
Several tests can be used to detect WNV antigens. 
Immunohistochemistry is often used on tissue samples 
collected at necropsy. Equine CNS does not contain large 
quantities of virus, and immunohistochemistry can detect 
some, but not all, infected animals. In contrast, this test may 
detect antigens in multiple organs, as well as the CNS, in 
alligators and some species of birds. One study found that the 
spleen, liver, kidney and duodenum contained antigens in 
almost all crows infected in the wild. Antigen-capture ELISA 
tests can also be used to find antigens in avian tissues; 
however, they are not useful in horses, which have much 
lower levels of virus. An antigen capture dipstick assay is 
valuable for rapid testing of oral or cloacal swabs from live 
birds, and tissue homogenates from dead birds. The antigen-
capture ELISA and the antigen-capture dipstick assay are 
also used for mosquito surveillance. Cross-reactions with 
closely related flaviviruses can occur in antigen tests. 
Serological tests for WNV include various ELISAs, 
hemagglutination inhibition (HI), virus neutralization 
assays (the plaque reduction neutralization, or PRN assay) 
and other tests. Cross-reactive antibodies to closely related 
flaviviruses are also detected by the ELISAs, HI and some 
other tests, but can be distinguished with the PRN test. This 
test is also used to confirm positive or equivocal ELISAs in 
horses. A disadvantage to the PRN test is that it must be 
performed in a BL 3 laboratory, and it is not available at all 
diagnostic laboratories. Serological tests are particularly 
valuable in live horses, where they are often used to 
diagnose clinical cases. A four-fold or greater increase in 
WNV-specific antibodies in serum, the detection of specific 
IgM in CSF, or the detection of specific IgM in serum 
confirmed by specific IgG in the same or a later sample are 
diagnostic. If clinical signs have not been present long 
enough for IgG to develop, the presence of IgM alone in 
serum is suggestive. Serology is also valuable in birds, as 
well as some mammals other than horses; however, it 
should be noted that some ELISAs can only be used in the 
species for which they have been standardized. Vaccination 
history must be considered when interpreting serological 
tests in horses and in some birds (e.g., geese and California 
condors).  
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Treatment 
No specific treatment is available, but animals may 
recover on their own if they are given supportive care. 
Supportive treatment has the goal of reducing inflammation 
in the CNS, preventing self-inflicted injuries and adverse 
effects from recumbency, and providing supportive 
nutrition and fluids. Therapy is empiric, and similar to the 
treatment of other causes of viral encephalomyelitis. Mild 
cases have sometimes recovered without treatment. 
Control 
Disease reporting 
Veterinarians who encounter or suspect a West Nile 
virus infection should follow their national and/or local 
guidelines for disease reporting.  
Animal cases are a warning that humans may be at risk 
from mosquito-borne transmission. Although West Nile 
virus is endemic in the U.S., infections are reportable in 
many states. Some states require that all horses with signs 
of encephalomyelitis be reported. In some countries, 
authorities collect dead birds for West Nile virus 
surveillance. In the U.S., state and/or wildlife agencies 
should be contacted for information about the current 
programs. 
Prevention  
Commercial WNV vaccines are available for horses in 
the U.S. and other countries, and for geese in Israel. 
Vaccines are sometimes used “off label” to protect sensitive 
birds (e.g., endangered California condors) or other species. 
Topical repellents may reduce the risk of WNV 
during the mosquito season. Repellents should be 
approved for the species; products that are safe in one 
species (including humans) can sometimes be toxic in 
others. Housing susceptible species indoors or in screened 
barns, cages or other screened areas can also decrease 
mosquito bites. Fans can be helpful in barns, as 
mosquitoes are not strong flyers. Insecticides or mosquito 
traps may also be used. Areas around barns, paddocks and 
pastures should be kept free of weeds, feces and other 
organic materials that could shelter adult mosquitoes. 
Standing or stagnant water should be eliminated to 
prevent them from breeding. Water tanks and buckets 
should be cleaned at least weekly, and containers (e.g. 
flower pots and used tires) should be removed or emptied 
of water. In some areas, ponds may be stocked with 
mosquito fish (Gambusia affinis), which feed on mosquito 
larvae. The inconveniences from mosquito control 
measures such as indoor housing can be weighed against 
the risk of infection in each species. For example, some 
species of birds are highly susceptible to WNV, but cases 
in dogs, cats and sheep are rare. In some areas, agencies 
conduct mosquito abatement programs using larvicides, 
adulticides and other measures to reduce mosquito 
populations. 
Other measures, such as quarantines of infected 
animals, may be helpful in species suspected or known to 
transmit the virus horizontally. Carnivores and omnivores 
should not be allowed to eat any meat that might be 
contaminated with WNV. One outbreak occurred in 
alligators that had been fed WNV-infected horsemeat. 
Tissues from some birds are also known to contain high 
levels of virus. 
Morbidity and Mortality 
Clinical cases caused by WNV usually occur seasonally. 
Birds are mainly affected from summer to late fall, and cases 
in horses peak in late summer and fall. Occasional outbreaks 
may be seen when mosquitoes are absent, in species that can 
transmit the virus horizontally. In the U.S., one outbreak 
occurred among crows during the winter. WNV isolates 
differ in their virulence for birds, and only some viruses 
cause severe illness or death. Different patterns of disease 
have been reported among avian species in the Eastern and 
Western Hemispheres. 
Birds in North America 
With minor exceptions (e.g., some individual animals in 
zoos), birds in the Western Hemisphere were first exposed to 
WNV in 1999. Some North American populations of wild 
birds experienced high mortality rates. Corvids were severely 
affected. Overall, the number of crows in the U.S. fell by an 
estimated 30%, with much greater decreases in some 
localized areas. Declines were also measured in populations 
of blue jays (Cyanocitta cristata). Greater sage grouse are 
also highly susceptible to WNV, and some local populations 
of these birds were severely affected. Nearly all of the 
breeding birds died in some areas. In the Powder River basin 
of Montana and Wyoming, the minimum mortality rate from 
WNV-infection in sage grouse was 2-13% in 2003-2005, and 
the maximum possible mortality rate was 8-29%. In raptors, 
one study estimated the annual mortality rate from WNV 
infections to be 7-15%. Other affected populations included 
American robins, eastern bluebirds, chickadees, tufted 
titmice, house sparrows, house wrens, house finches and 
black-crowned night herons, with declines either after intense 
epidemics or over longer periods. In some cases, the number 
of birds fell across their entire range; in others, the decreases 
were regional. With time, some species (for example, crows, 
blue jays and house wrens) have apparently recovered or are 
recovering; other populations remained smaller than normal. 
In contrast, the abundance of some birds does not seem to 
have been affected by WNV. While some of these unaffected 
species may not be very susceptible to WNV, this is not 
necessarily true in all cases. For example, a wild population 
of northern cardinals was shown to be affected by the virus, 
although this population as a whole appeared to be resilient 
and did not decline. WNV may also affect some age groups 
more than others. It appears to cause significant mortality in 
American white pelican chicks in North America, although 
adults are not severely affected.  
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In zoos and rehabilitation centers, WNV has affected a 
wide variety of avian species. During one outbreak at a 
New York zoo, the overall morbidity rate among infected 
birds was estimated to be 14%; it was higher among species 
found in the Western Hemisphere (20%) than species 
indigenous to Eastern Hemisphere (5%). In this outbreak, 
the morbidity rate was high in corvids, owls and penguins, 
but only 9% of infected gallinaceous birds became ill. Most 
clinical cases ended in death; the case fatality rate was 69% 
overall, and in most orders, it reached 100%. A high case 
fatality rate was also reported during an outbreak at Kansas 
zoos: only one of 11 affected birds, a sandhill crane, 
survived. Among raptors, symptomatic infections have been 
documented in both falconiformes and owls. Widely 
varying mortality rates have been reported among owls at 
rehabilitation centers, with some species experiencing 
mortality rates of greater than 90%, while others suffered 
no deaths.  
Among poultry, young geese seem to be particularly 
susceptible to WNV, and have been affected in both 
Western and Eastern Hemispheres. In Israel, disease was 
reported in 3-8-week-old goslings, with morbidity and 
mortality rates of approximately 40%. During an outbreak 
in Canada, the mortality rate was 25% in 6-week-old 
goslings, but 15-month-old and 5-year-old geese 
seroconverted with no clinical signs. In experimental 
infections, up to 50–75% of geese may die. Ducks are not 
thought to be highly susceptible to WNV; however, an 
outbreak among captive lesser scaup (Aythya affinis) 
ducklings resulted in 70% mortality. During other 
outbreaks, the morbidity and mortality rates were 100% in 
Impeyan pheasants, and the mortality rate was 25% in 
chukar partridges. Similarly to geese, young partridges and 
pheasants seem to be more susceptible to disease. In 
contrast, both young and old chickens and turkeys are 
infected asymptomatically.  
A limited number of bird species have been 
experimentally infected with North American strains of 
WNV. These studies demonstrate that susceptibility varies 
greatly between avian species. Mortality rates as high as 
100% have been reported in American crows (Corvus 
brachyrhynchos), black-billed magpies (Pica hudsonia), 
ring-billed gulls, house finches and greater sage grouse. 
Mortality was 75% in blue jays (Cyanocitta cristata), 53% in 
fish crows (Corvus ossifragus), 16% in house sparrows and 
0% in cliff swallow nestlings. In addition to the species, 
factors that may affect the severity of disease include pre-
existing immunity to WNV, co-existing conditions and 
general health, and possibly the route of exposure. 
Birds in South and Central America 
Few detailed studies have been conducted on WNV 
mortality among birds in South and Central America, 
Mexico and the Caribbean. Overall, these birds are thought 
to have been less severely affected than birds in North 
America.  
Birds in the Eastern Hemisphere 
In areas where WNV has been endemic for decades, the 
prevalence of infection in wild birds ranges from 10% to 
greater than 50%. While WNV outbreaks have been 
reported among domesticated geese in the Eastern 
Hemisphere, there have generally been only sporadic reports 
of deaths in wild birds, and no major mortality events have 
been reported. It is uncertain whether this is related to the 
virulence of the viruses circulating in this region, lower host 
susceptibility (including immunity from repeated exposure), 
reduced transmission/ amplification or lack of surveillance. 
However, one recently introduced lineage 2 virus in Central 
Europe has affected significant numbers of wild and captive 
raptors. Species known to be susceptible to this isolate 
include sparrow hawks (Accipiter nisus), goshawks 
(Accipiter gentilis) and gyrfalcons (Falco rusticolus). Dead 
songbirds of various species have also been diagnosed 
occasionally with WNV in this area. The same virus was 
isolated from a dead collared dove in Italy, during an 
outbreak of mortality in collared doves and other species 
including blackbirds. Other lineage 1a or 2 viruses have also 
been found occasionally in sick or dead birds. For example, 
lineage 1a viruses have killed raptors in Spain, and a 
lineage 1a virus was detected in a dead magpie and a 
moribund wild house sparrow with torticollis and tremors 
during a WNV outbreak in France. No unusual mortality 
was otherwise observed in birds during the latter outbreak, 
but systematic examinations of bird populations were not 
carried out.  
A few European species have been shown to be 
susceptible to illness after experimental inoculation of 
WNV. Red-legged partridges infected with two European 
lineage 1 viruses had mortality rates of 30% or 70%. Both 
lineage 1 and lineage 2 European viruses caused illness and 
some deaths in experimentally infected falcons, with both 
viruses causing a similar clinical picture. In one study, the 
illness was fatal in a third of the falcons inoculated with an 
Austrian lineage 2 WNV strain. In other experiments using 
European birds, the mortality rates were 0-25% in house 
sparrows inoculated with WNV isolates from Italy or Spain, 
33% in wild carrion crows inoculated with a lineage 1 
equine isolate from France, and 100% in wild carrion crows 
inoculated with an avian (stork) lineage 1 isolate from 
Israel. 
Equids 
Among domesticated mammals, West Nile outbreaks 
occur mainly in equids. Many infections in horses are 
asymptomatic. While seroprevalence rates vary greatly 
between studies (and cross-reactivity with other 
flaviviruses can be a concern), up to 90% of horses are 
reported to be seropositive in some parts of Africa. During 
outbreaks, 10-43% of infected horses are estimated to 
develop neurological signs. The reported case fatality rate 
ranges from 23% to 57%. It is approximately 30-40% in 
the U.S., and was 30% during a lineage 2 outbreak in 
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Hungary. Although some horses that recover have residual 
neurological defects, approximately 80-90% (60-100% in 
individual studies) are estimated to return to full function. 
As with other species, the impact of WNV on horses 
seems to have been greater in North America than in other 
parts of the Americas.  
Ruminants and other livestock 
Livestock are uncommonly affected by WNV, although 
seropositive animals are relatively common in some regions. 
A few clinical cases have been reported in sheep, alpacas and 
reindeer, but even in North America, clinical signs have been 
limited to one to a few animals in the herd. However, 
approximately 26% of camels, 20% of sheep, 18% of goats 
and 6% of cattle in Nigeria had antibodies to WNV in the HI 
test, while 29% of camels in Morocco were confirmed to be 
seropositive by virus neutralization (44% were seropositive 
by HI). In the Astrakhan region of Russia, antibodies were 
confirmed by virus neutralization in small numbers of cattle, 
sheep, pigs and camels; in all species, the seroprevalence rate 
was less than 6.5% by HI and less than 5% by virus 
neutralization. Similarly, less than 1% of cattle in Croatia, 
<1% to 6% of cattle in Belarus, and 1% of sheep in eastern 
Slovakia were seropositive. One study reported that 4% of 
cattle and 1% of sheep in Turkey had WNV antibodies, while 
a report from northern Turkey found antibodies in 3% of 
goats, and no cattle, sheep or water buffalo. Symptomatic 
infections have not been reported in pigs, but approximately 
3-10% of domesticated pigs in India, 3% of domesticated 
pigs in Nepal, 3% of pigs in Spain and 22% of feral pigs in 
Florida, Georgia, and Texas were seropositive.  
Dogs and cats 
Only rare clinical cases have been reported in dogs and 
cats, and they develop few or no clinical signs after 
experimental infection. However, asymptomatic infections 
may be common, as significant numbers of dogs and cats 
have antibodies to WNV. The seroprevalence among dogs 
was reported to be 8-37% in South Africa, 38% in Turkey, 
5% in Shanghai, China and 2-56% in localized areas of the 
U.S. In two studies from the U.S. studies, the seroprevalence 
rates were 9-10% in cats, while another U.S. study detected 
no antibodies among 12 cats. In Shanghai, China, 15% of 
cats had antibodies to WNV.  
Wild mammals 
Antibodies have also been reported in many species of 
wild mammals, and infections may be common in the 
members of some species. In the U.S., up to 63% of striped 
skunks, up to 46% of raccoons and up to 49% of squirrels in 
some areas may have antibodies to WNV. In Spain, 
antibodies to WNV or closely related flaviviruses were 
detected by ELISA in 13% of wild boars and 20% of red 
foxes (Vulpes vulpes). Only a few of the approximately 650 
samples could also be analyzed by virus neutralization, but 
43% of 21 samples from wild boars and the one sample 
analyzed from a fox were found to contain antibodies to 
WNV. High seroprevalence rates were also reported in a 
recent study of wild lemurs in Madagascar. The susceptibility 
of most species to WNV is unknown, but occasional clinical 
cases have been reported in a wide variety of species in zoos. 
Squirrels may be especially susceptible. In some regions, sick 
and dead squirrels have been seen during periods of high 
WNV activity, and the morbidity rate in experimentally 
infected fox squirrels was 10%.  
Case fatality rate in mammals other than horses 
Once a mammal develops neurological signs, the case 
fatality rate seems to be high. Most clinically affected 
animals, which included sheep, alpacas, reindeer, dogs, 
cats, wolves, deer and a bear, have died, although one 
alpaca with relatively mild neurological signs recovered. 
Both rhinoceroses affected in a zoo and one of two seals 
also recovered. 
Reptiles 
Among reptiles, disease has been reported only in 
alligators, one lizard (a crocodile monitor) and 
experimentally infected garter snakes. At one U.S. alligator 
farm with more than 10,000 animals, 250 alligators died in an 
outbreak one year, and more than 1,000 died the following 
year. Young alligators were more severely affected than 
adults.  
Infections in Humans 
Incubation Period 
The incubation period is approximately 2 to 14 days. It 
is reported to be longer in transplant patients than in people 
who are not immunocompromised. 
Clinical Signs 
Human illness has been classified into two forms: West 
Nile fever, which is a flu-like illness, and West Nile 
neuroinvasive disease, which encompasses all cases with 
neurological signs. Many WNV infections are 
asymptomatic. 
West Nile fever is the most common form of the 
disease. This form resembles influenza, and is characterized 
by fever, malaise, weakness, headache and body aches. 
Anorexia, lymphadenopathy, nausea, diarrhea, vomiting, 
sore throat and conjunctivitis may be seen in some patients. 
An erythematous, nonpruritic macular, papular or 
morbilliform skin rash occasionally develops on the neck, 
trunk, arms or legs. Most uncomplicated infections resolve 
in 2 to 6 days, but in some severe cases, persistent fatigue 
can last for a month or more.  
Although many cases of West Nile fever are mild, 
there have also been reports of severe illness, and death is 
possible, though rare. In the U.S., fatal West Nile fever has 
occurred mainly in elderly patients, who frequently had 
underlying health conditions. In most cases, the illness 
appears to have exacerbated or precipitated an underlying 
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medical condition, resulting in death from acute myocardial 
infarction, cardiac arrhythmia, respiratory failure, stroke, 
cancer or other conditions. Death was often the result of 
cardiac or respiratory complications.  
A few patients with West Nile fever develop West Nile 
neuroinvasive disease. This form can be severe, and in 
some cases, it is life-threatening. Three syndromes - 
encephalitis, meningitis, and acute flaccid paralysis – are 
seen. Symptoms of more than one syndrome often occur in 
the same patient. West Nile meningitis is characterized by 
fever, headache, a stiff neck and photophobia. Patients with 
West Nile encephalitis have changes in consciousness, 
disorientation and/or focal neurological signs, which may 
include ataxia, incoordination, tremors, involuntary 
movements, and signs that resemble Parkinson’s disease 
(rigidity, postural instability and bradykinesia). Concurrent 
signs of meningitis are common, and seizures or coma may 
also occur. Some patients who recover have persistent 
neurological dysfunction. 
Acute flaccid paralysis (sometimes called West Nile 
poliomyelitis) is seen in some patients. The paralysis, which 
resembles polio, appears suddenly and progresses rapidly, 
usually reaching a plateau within hours. It is typically 
asymmetrical and can affect one or more limbs, often the 
legs. The weakened limbs become darker than normal at the 
peak of the paralysis. This syndrome may be accompanied 
by muscle aches in the lower back and/or abnormalities in 
bladder and bowel function. Some patients develop 
respiratory distress, which may require mechanical 
ventilation. Sensory functions are usually normal or 
minimally affected. Some patients with flaccid paralysis 
have prodromal signs of West Nile fever, sometimes with 
signs of meningitis or encephalitis; however, many patients 
are asymptomatic before the onset of paralysis. Late in the 
illness, the muscles may become atrophied. Recovery is 
highly variable: some patients recover completely within 
weeks, while others remain paralyzed.  
Cranial nerve abnormalities in patients with 
neuroinvasive disease may result in facial weakness, 
dizziness, vertigo or nystagmus. Rhabdomyelitis, 
myositis, polyradiculitis and other syndromes have also 
been seen. Many individuals complain of blurred or 
impaired vision and photophobia; ocular syndromes that 
have been reported include chorioretinitis, uveitis, vitritis 
and optic neuritis. 
Other syndromes have occasionally been reported. 
Myocarditis, pancreatitis, orchitis and fulminant hepatitis 
are uncommon, but have been seen in some outbreaks. A 
life-threatening hemorrhagic syndrome occurred in a few 
West Nile cases in Africa, and was reported in a patient in 
the U.S. Acute kidney disease has been seen in some 
patients with WNV encephalitis. Possible associations 
between West Nile neurological disease and chronic kidney 
disease have also been suggested by some authors, but a 
causative role remains to be confirmed. 
Diagnostic Tests 
In humans, West Nile virus infections are often 
diagnosed by serology. Serological tests used in humans 
include ELISAs, a rapid microsphere-based fluorescence 
immunoassay (MIA), the plaque reduction neutralization 
(PRN) test, indirect immunofluorescence (IFA) and 
hemagglutination inhibition. Diagnostic criteria include a 
rising titer or the presence of IgM in serum or cerebrospinal 
fluid (CSF). In the serum, anti-WNV IgM can occasionally 
persist for more than a year. Serum IgM is thus suggestive of 
recent infection, but not definitive. This is not a concern for 
IgM in CSF. As in animals, cross-reactions can occur with 
closely related flaviviruses (e.g., yellow fever, Japanese 
encephalitis, St. Louis encephalitis or dengue viruses) in 
some serological tests. Positive reactions in other serological 
tests may be confirmed with the PRN test, if available. 
Infectious viruses, viral antigens or nucleic acids can 
sometimes be detected in human tissues, CSF, blood, urine 
and other body fluids. This virus can usually be found in the 
blood of patients with West Nile fever during the first few 
days after the onset of illness. However, viremia usually 
disappears before the onset of neurological signs in 
immunocompetent patients, and viral RNA is often absent 
from the serum of patients with neuroinvasive disease. In 
these patients, nucleic acids may be detected in the CSF, 
using RT-PCR tests, during the acute stage of CNS signs. 
Immunohistochemistry to detect viral antigens is mainly 
used postmortem in fatal cases. Virus isolation requires 
level 3 biosafety containment, and is rarely performed. 
Treatment 
There is no specific recommended treatment, other 
than supportive care, at present. Intensive care and 
mechanical ventilation may be required in some cases. 
Various therapies including interferon, antisense 
nucleotides and intravenous immunoglobulins (passive 
immunization) are being tested in clinical trials. While a 
few case reports suggest that some of these treatments may 
be promising, larger studies are still lacking. Some antiviral 
drugs were promising in vitro, but most have been 
ineffective when tested in animal models or given to 
humans with severe disease. Screening for new drugs that 
may inhibit WNV is underway. 
Control 
In most cases, WNV infections can be prevented by 
preventing mosquito bites. Outdoor activities should be 
limited when mosquitoes are active, particularly during the 
peak biting times of dusk and dawn. Mosquito repellents 
should be used when avoidance is impractical. Long pants 
and long-sleeved shirts are helpful; specialized fine mesh 
clothing (e.g., mesh head coverings and jackets) is also 
available. Measures to reduce mosquito populations include 
rational application of adulticides and larvicides, as well as 
environmental modifications such as emptying containers 
that may hold standing water. Surveillance in sentinel birds, 
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dead birds and mosquitoes can help predict human 
exposure. Dead or sick birds should be reported to health, 
agriculture or mosquito-control agencies. In some cases, 
only certain species or groups of birds, such as corvids, may 
be tested for WNV. Dead animals should never be handled 
without gloves and sanitary precautions, as feces and body 
fluids may be infectious in some species (and may also 
contain pathogens other than WNV). 
Veterinarians, wildlife rehabilitators, wildlife 
biologists, laboratory workers and others should practice 
good biosecurity and hygiene when handling either tissues 
or birds, mammals, reptiles and amphibians that may shed 
WNV in feces, oral secretions or urine. Mucous membranes 
and skin should be protected from contact with infectious 
material, such as tissues or secretions and excretions. Under 
some conditions, respiratory protection might be needed. 
Protective clothing and gloves should be used when 
performing necropsies.  
How soon a human vaccine might become available is 
uncertain, but some vaccines have entered or completed 
clinical trials. Blood products are screened for WNV in 
some countries, to prevent transfusion-associated cases. 
Morbidity and Mortality 
West Nile infections usually occur in humans during 
warm weather, when mosquitoes are active. Outbreaks of 
West Nile disease appear to be sporadic, as well as 
geographically focal in their distribution, with shifts in their 
locations from year to year. Some of the factors that might 
affect the occurrence of outbreaks include weather patterns, 
the number and distribution of mosquitoes, and herd 
immunity in amplifying hosts; however, the interactions of 
these factors in producing outbreaks are likely to be 
complex, and outbreaks are difficult or impossible to 
predict.  
The epidemiology of WNV infections appears to 
differ between geographic regions, although differences in 
surveillance and diagnostic testing may also play a part in 
this perception. In some parts of Africa, there seems to be 
relatively little mortality in people. Although severe 
disease can occur, it is thought that people tend to become 
infected as children, and are immune by the time they 
become more susceptible to neuroinvasive disease as 
adults. In many parts of Europe, the usual pattern of WNV 
epidemiology has been that of occasional, self-limited 
outbreaks affecting very few people. Larger and more 
severe outbreaks are also reported occasionally. For 
example, nearly 200 cases of neuroinvasive disease were 
documented during an outbreak in Greece in 2010. This 
and other recent outbreaks, together with evidence that 
some viruses may have become endemic, has led to the 
suggestion that the epidemiology of WNV infections may 
be changing in Eurasia. In North America, large numbers 
of West Nile fever cases, and much fewer cases of 
neuroinvasive disease, have been seen: more than 13,000 
cases of West Nile fever were reported to the CDC 
between 2002 and 2006. Based on the pattern of infections 
in North America so far, including a peak in the number 
of cases in 2002-2003, followed by declines, then another 
upsurge in 2012, periodic outbreaks and epidemics may be 
expected in the future. Surprisingly, far fewer clinical 
cases or deaths have been reported in Central and South 
America. The reason for this is not known; however, it 
might involve protective immunity to cross-reactive 
flaviviruses, the occurrence of WNV isolates with 
decreased virulence, decreased surveillance and diagnosis, 
or other causes. In areas where dengue is present, some 
West Nile infections could be misdiagnosed as this 
disease. 
Most human infections with WNV are asymptomatic. 
Approximately 20% of those infected during recent 
outbreaks in the U.S., Europe and Israel developed West 
Nile fever, and less than 1% had West Nile neuroinvasive 
disease. Neuroinvasive disease is more likely to occur in 
people over 50 years of age and patients who are 
immunocompromised. In a study from North Dakota, the 
risk varied from 1 in 54, in people over the age of 65, to 1 
in more than 1,200 in young, low risk individuals. A study 
from Ohio estimated approximately 1 case of 
neuroinvasive disease for every 4,000 infected children, 
154 infected adults under the age of 65 years, or 38 
infected adults who were more than 65. Recipients of 
organ transplants are estimated to have a 40% chance of 
developing neuroinvasive disease. Underlying diseases 
such as diabetes and autoimmune syndromes are also 
associated with more severe clinical signs.  
Case fatality rates reported during outbreaks have 
ranged from 3% to 15%, but the case fatality rate varies 
with the form of the disease. West Nile fever is typically 
self-limited, and many cases are mild. However, more 
severe illnesses have also been reported, and deaths are 
possible, though uncommon. In a recent analysis of cases 
in the U.S., approximately 0.2% of West Nile fever cases 
reported to the CDC between 2002 and 2006 were fatal. 
(Milder cases are likely to be underdiagnosed, and are 
probably underrepresented in this database.) Of the fatal 
cases, 78% occurred in patients who were older than 70 
years of age. Many affected patients had underlying health 
conditions, and most of these deaths appeared to result 
from the exacerbation or precipitation of these illnesses, 
similarly to the effects of influenza on the elderly. For 
West Nile neuroinvasive disease, the overall case fatality 
rate is approximately 10%. Death is more likely to occur 
in older patients; case fatality rates of 15-29% have been 
seen in people who are more than 70 years old. Some 
patients with neuroinvasive disease may suffer substantial 
long-term morbidity after recovery from the acute 
syndrome. Patients with encephalitis are more likely to 
have a poor prognosis and long term sequelae than those 
with meningitis alone.  
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Internet Resources 
Centers for Disease Control and Prevention (CDC) 
http://www.cdc.gov/westnile/index.html 
Public Health Agency of Canada. Material Safety Data Sheets   
http://www.phac-aspc.gc.ca/lab-bio/res/psds-ftss/index-
eng.php  
The Merck Manual 
http://www.merckmanuals.com/professional/index.html 
The Merck Veterinary Manual 
http://www.merckmanuals.com/vet/index.html 
United States Department of Agriculture (USDA) Animal and 
Plant Health Inspection Service (APHIS). Equine West Nile 
Virus. 
http://www.aphis.usda.gov/vs/nahss/equine/wnv/ 
World Organization for Animal Health (OIE) 
http://www.oie.int 
OIE Manual of Diagnostic Tests and Vaccines for  
Terrestrial Animals  
http://www.oie.int/international-standard-setting/terrestrial-
manual/access-online/ 
OIE Terrestrial Animal Health Code 
http://www.oie.int/international-standard-
setting/terrestrial-code/access-online/ 
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